newsfilter
← Latest News
GlobeNewswire·

Miromatrix Announces FDA Clinical Hold on IND Application for miroliverELAP

EDEN PRAIRIE, Minn., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ:MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and